MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it plans to release second quarter 2023 financial and…Read More
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
